Today, Michael Smedley commented about whether ART-X, UFS-T, VII-T, GEI-T, WRG-T, BB-T, DHX.B-T, KLS-T, NDM-T, DML-T, DGC-T, CCL.B-T, AFN-T, MFC-T, CMI-X, UR-T, CXI-T, PHM-X, CPH-T, ASG-X, RX-X, TECK.B-T, GUD-T, CXR-T are stocks to buy or sell.
Have been getting clearance for their spinal devices in the US, England and most recently in Canada. They are in the build process, exhibiting patients, working hard to get into the hospitals, and have launched an additional product. Have about 12 competitors. The stock ran too far, right in the beginning. He will continue to hold.
Just got through a new level of approval with the Association of American railroads and have got some contract acceptance into one of the main railcar builders. This should stay strong. Has good engineering. Plants in Texas. Seems to be one-of-a-kind for better man ways (?) and valves for better rail cars. This is still in the development stage of getting the contract work going. Be patient.
This is one that you should just stay with. Because of the condition of the market, you don’t expect anything to be rip roaring upwards unless it has special news. This is a very, very nice company. Steady, reliable.